Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses
Received 17 November 2009; received in revised form 12 April 2010; accepted 16 May 2010. published online 21 June 2010. Corrected Proof
Abstract
The study aimed to determine whether post-radiation vaginal side effects in cervical cancer patients can be correlated with DVH parameter D2cc. The result was negative in that no correlation could be demonstrated between D2cc and the presence and grade of side effects in this patients’ subset treated with high brachytherapy doses.
aDepartment of Radiotherapy, Medical University of Vienna, Vienna, Austria
bDepartment of Radiotherapy, Christian-Albrechts University Kiel, Kiel, Germany
Corresponding author. Address: Department of Radiotherapy, Medical University of Vienna, General Hospital of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.